Dhanuka Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 09-11-2024
- Paid Up Capital ₹ 2.38 Cr
as on 09-11-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 280.60 Cr
as on 09-11-2024
About Dhanuka Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.38 Cr.
The company currently has active open charges totaling ₹280.60 Cr.
Kailash Dhanuka, Sunil Dhanuka, and Yogesh Mangal serve as directors at the Company.
- CIN/LLPIN
U24239MP2021PTC056476
- Company No.
056476
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2021
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Neemuch, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dhanuka Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kailash Dhanuka  | Director | 29-Jun-2021 | Current |
| Sunil Dhanuka | Director | 29-Jun-2021 | Current |
| Yogesh Mangal | Additional Director | 08-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Dhanuka Biotech.
Dhanuka Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dhanuka Biotech?
Unlock access to Dhanuka Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dhanuka Soya Private LimitedActive 11 years 8 monthsKailash Dhanuka and Sunil Dhanuka are mutual person
- Shree Nath Vincom Private LimitedActive 15 years 11 months
Kailash Dhanuka and Sunil Dhanuka are mutual person
- Dhanuka Solutions Private LimitedActive 2 years 10 months
Kailash Dhanuka and Sunil Dhanuka are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Nov 2022 | ₹8.70 M | Open |
Yes Bank Limited Creation Date: 21 Nov 2022 | ₹4.71 Cr | Open |
Others Creation Date: 30 Jun 2022 | ₹275.00 Cr | Open |
How Many Employees Work at Dhanuka Biotech?
Unlock and access historical data on people associated with Dhanuka Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhanuka Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanuka Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
